Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Oil Fund LP
USO
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
No Data
H.C. Wainwright Maintains In8bio(INAB.US) With Buy Rating, Maintains Target Price $6
Analysts Offer Insights on Healthcare Companies: Kodiak Sciences (KOD), IN8bio (INAB) and Ultragenyx Pharmaceutical (RARE)
JonesTrading Initiates In8bio(INAB.US) With Buy Rating, Announces Target Price $5
IN8bio GAAP EPS of -$0.26
Mizuho Securities Maintains In8bio(INAB.US) With Buy Rating, Maintains Target Price $4
Wall Street Analysts Are Bullish on Top Healthcare Picks